Integrative analysis of proteomics and metabolomics of anaphylactoid reaction induced by Xuesaitong injection

Journal of Chromatography A

Volumn 1416, Issue , 2015, Pages 103-111

  Xu, Yubin ^a   Dou, Deqiang ^a   Ran, Xiaoku ^a   Liu, Chunyan ^a   Chen, Jing ^a  

^a LIAONING UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Anaphylactoid reaction; Mechanism; Metabolomics; Proteomics

Indexed keywords

AMINO ACIDS; BIOMARKERS; HEALTH RISKS; MECHANISMS; METABOLISM; METABOLITES; PROTEINS;

ADVERSE DRUG REACTION (ADRS); ANAPHYLACTOID REACTION; ARACHIDONIC ACIDS; INTEGRATIVE ANALYSIS; METABOLOMICS; NATURAL COMPOUNDS; PROLINE METABOLISM; REFERENCE STANDARD;

PROTEOMICS;

ADENINE; ADENOSINE; ARACHIDONIC ACID; ARGININE; ARGININOSUCCINATE LYASE; ARGININOSUCCINATE SYNTHASE; BLOOD CLOTTING FACTOR 12; BLOOD CLOTTING FACTOR 13B; CITRIC ACID; COMPLEMENT; COMPLEMENT COMPONENT C2; COMPLEMENT COMPONENT C4D; COMPLEMENT COMPONENT C6; DERMCIDIN; GLUTATHIONE; GLUTATHIONE PEROXIDASE 1; HERBACEOUS AGENT; HIPPURIC ACID; HISTAMINE; HISTIDINE; ISOCITRIC ACID; KININOGEN; LEUKOTRIENE B4; PEROXIREDOXIN 2; PROLINE; PURINE; TERMINAL COMPLEMENT COMPLEX; UNCLASSIFIED DRUG; UNINDEXED DRUG; URIC ACID; XUESAITONG; BIOLOGICAL MARKER;

ALLERGENICITY; AMINO ACID METABOLISM; ANAPHYLAXIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARACHIDONIC ACID METABOLISM; ARTICLE; CITRIC ACID CYCLE; COMPLEMENT SYSTEM; CONTROLLED STUDY; CONVULSION; DEATH; DOWN REGULATION; DYSPNEA; ENZYME LINKED IMMUNOSORBENT ASSAY; KALLIKREIN KININ SYSTEM; MALE; METABOLOMICS; MUSCLE SPASM; MYASTHENIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; PURINE METABOLISM; RAT; SNEEZING; UNSTEADY GAIT; UPREGULATION; ANIMAL; ANIMAL BEHAVIOR; BROWN NORWAY RAT; CHEMICALLY INDUCED; DISEASE MODEL; DRUG EFFECTS; ELECTROSPRAY MASS SPECTROMETRY; INJECTION; LIQUID CHROMATOGRAPHY; METABOLISM; PROCEDURES; TANDEM MASS SPECTROMETRY;

ANAPHYLAXIS; ANIMALS; BEHAVIOR, ANIMAL; BIOMARKERS; CHROMATOGRAPHY, LIQUID; DISEASE MODELS, ANIMAL; DRUGS, CHINESE HERBAL; INJECTIONS; MALE; METABOLOMICS; PROTEOMICS; RATS; RATS, INBRED BN; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; TANDEM MASS SPECTROMETRY;

EID: 84942192856     PISSN: 00219673     EISSN: 18733778     Source Type: Journal    
DOI: 10.1016/j.chroma.2015.09.019     Document Type: Article

References (31)

1. Liu J., Sun K., Zheng C., Chen X., Zhang W., Wang Z., Shar P.A., Xiao W., Wang Y. Pathway as a pharmacological target for herbal medicines: an investigation from reduning injection. PLOS ONE 2015, 10:e123109.
2. Xiang Z., Qiao T., Xiao H., Kang T.G., Dou D., Li H., Kuang H. The anaphylactoid constituents in Xue-Sai-Tong injection. Planta Med. 2013, 79:1043.
3. Mi Y.N., Ping N.N., Xiao X., Zhu Y.B., Liu J., Cao Y.X. The severe adverse reaction to vitamin k1 injection is anaphylactoid reaction but not anaphylaxis. PLOS ONE 2014, 9:e90199.
4. Li Z., Gao Y., Wang H., Liu Z. A rat model of Shuang Huang Lian injection-induced anaphylaxis. Asian Pac. J. Allergy Immunol. 2010, 28:185.
5. Szebeni J. Complement activation-related pseudoallergy: a new class of drug-induced acute immune toxicity. Toxicology 2005, 216:106.
6. Jurakic T.R., Marinovic B., Lipozencic J. Nonallergic hypersensitivity to nonsteroidal antiinflammatory drugs, angiotensin-converting enzyme inhibitors, radiocontrast media, local anesthetics, volume substitutes and medications used in general anesthesia. Acta Dermatovenerol. Croat. 2009, 17:54.
7. Farnam K., Chang C., Teuber S., Gershwin M.E. Nonallergic drug hypersensitivity reactions. Int. Arch. Allergy Immunol. 2012, 159:327.
8. Kun T., Jakubowski L. Influence of MRI contrast media on histamine release from mast cells. Pol. J. Radio 2012, 77:19.
9. Wang L., Li Z., Zhao X., Liu W., Liu Y., Yang J., Li X., Fan X., Cheng Y. A network study of Chinese medicine Xuesaitong injection to elucidate a complex mode of action with multicompound, multitarget, and multipathway. Evid. Based Complement. Alternat. Med. 2013, 2013:652373.
10. Zhang X., Wu J., Zhang B. Xuesaitong injection as one adjuvant treatment of acute cerebral infarction: a systematic review and meta-analysis. BMC Complement. Altern. Med. 2015, 15:36.
11. Xiao R.M., Qiu X.Q., Su J.F. New progress of pharmacological study of Panax notoginseng saponin for treating cardiovascular disease, China. Healthcare Innov. 2009, 4:30.
12. Yin C.Q., Deng H.S., Cheng J. Overview of the pharmacological effects of Panax notoginseng saponin for blood, cardiovascular and central nervous system. Sci. Technol. Inf. 2010, 29:50.
13. Wang S., Zhu Q., Yi L. The effect of Xuesaitong injection on C-reactive protein in patients with acute coronary syndrome. Medical Recapitulate 2007, 8:37.
14. De L.Y. Curative effect of Xuesaitong injection on acute cerebral infarction of 50 patients. Pract. Clin. Med. 2007, 12:12.
15. Xu Y.B., Kang T.G., Dou D.Q., Kuang H.X. The evaluation and optimization of animal model for anaphylactoid reaction induced by injections. Asian Pac. J. Allergy Immunol. 2015, 33. 10.12932/AP0619.33.4.2015.
16. Wang Z., Wang D., Sui Y., Cui H., Yu Y. Experimental study on anaphylaxis of qingkailing injection and its components on Beagle dogs. J. Tradit. Chin. Med. 2012, 32:641.
17. Li X.M., Srivastava K., Grishin A., Huang C.K., Schofield B., Burks W., Sampson H.A. Persistent protective effect of heat-killed Escherichia coli producing "engineered," recombinant peanut proteins in a murine model of peanut allergy. J. Allergy Clin. Immunol. 2003, 112:159.
18. Asano E., Ebara T., Yamada-Namikawa C., Kitaori T., Suzumori N., Katano K., Ozaki Y., Nakanishi M., Sugiura-Ogasawara M. Genotyping analysis for the 46C/T polymorphism of coagulation factor XII and the involvement of factor XII activity in patients with recurrent pregnancy loss. PLOS ONE 2014, 9:e114452.
19. Sala-Cunill A., Bjorkqvist J., Senter R., Guilarte M., Cardona V., Labrador M., Nickel K.F., Butler L., Luengo O., Kumar P., Labberton L., Long A., Di Gennaro A., Kenne E., Jamsa A., Krieger T., Schluter H., Fuchs T., Flohr S., Hassiepen U., Cumin F., McCrae K., Maas C., Stavrou E., Renne T. Plasma contact system activation drives anaphylaxis in severe mast cell-mediated allergic reactions. J. Allergy Clin. Immunol. 2015, 135:1031.
20. Grossmann A., Wendel A. Non-reactivity of the selenoenzyme glutathione peroxidase with enzymatically hydroperoxidized phospholipids. Eur. J. Biochem. 1983, 135:549.
21. Szebeni J., Baranyi L., Savay S., Milosevits J., Bodo M., Bunger R., Alving C.R. The interaction of liposomes with the complement system: in vitro and in vivo assays. Methods Enzymol. 2003, 373:136.
22. Wang H.S., Cheng F., Shi Y.Q., Li Z.G., Qin H.D., Liu Z.P. Hypotensive response in rats and toxicological mechanisms induced by shuanghuanglian, an herbal extract mixture. Drug Discov. Ther. 2010, 4:13.
23. Antunes A.S.D.N.M.A. Different strains of mice present distinct lung tissue mechanics and extracellular matrix composition in a model of chronic allergic asthma. Respir. Physiol. Neurobiol. 2009, 165:202.
24. Qiu L.Z.L.Z.S.D. Characteristics of anaphylactoid reaction induced by Shuanghuanglian injection. Chin. J. Pharmacol. Toxicol. 2013, 27:818.
25. Zipser R.D., Laffi G. Prostaglandins, thromboxanes and leukotrienes in clinical medicine. West. J. Med. 1985, 143:485.
26. Bai Y.J., Gao X.Y., Lu J.Q., Zhang H.G. A LC-MS-based method for quantification of biomarkers from serum of allergic rats. Molecules 2010, 15:3356.
27. Kool M., Willart M.A., van Nimwegen M., Bergen I., Pouliot P., Virchow J.C., Rogers N., Osorio F., Reis E.S.C., Hammad H., Lambrecht B.N. An unexpected role for uric acid as an inducer of T helper 2 cell immunity to inhaled antigens and inflammatory mediator of allergic asthma. Immunity 2011, 34:527.
28. Choi Y.H., Yan G.H., Chai O.H., Song C.H. Inhibitory effects of curcumin on passive cutaneous anaphylactoid response and compound 48/80-induced mast cell activation. Anat. Cell. Biol. 2010, 43:36.
29. Chanan-Khan A., Szebeni J., Savay S., Liebes L., Rafique N.M., Alving C.R., Muggia F.M. Complement activation following first exposure to pegylated liposomal doxorubicin (Doxil): possible role in hypersensitivity reactions. Ann. Oncol. 2003, 14:1430.
30. Ming Y., Hu J., Luo Q., Ding X., Luo W., Zhuang Q., Zou Y. Acute antibody-mediated rejection in presence of MICA-DSA and successful renal re-transplant with negative-MICA virtual crossmatch. PLOS ONE 2015, 10:e127861.
31. Zhang F., Wen Y., Guo X., Zhang Y., Wang S., Yang T., Shen H., Chen X., Tan L., Tian Q., Deng H.W. Genome-wide pathway-based association study implicates complement system in the development of Kashin-Beck disease in Han Chinese. Bone 2015, 71:36.